Table 2. IgM and IgG levels for ACL, β2GPI, and concentration of Lupus in patients
|
Autoantibodies |
Patients |
Control |
RR |
95%CI |
P value |
|
Mean ± SE |
|||||
|
19.2±4.2 |
3.3±1.0 |
4.2 |
3.9-4.4 |
<0.001 |
|
|
ACL IgG (AU/ml) |
22.5±2.3 |
2.9±1.2 |
5.6 |
5.1-6.0 |
<0.001 |
|
β2GPI IgM (AU/ml) |
5.6±1.3 |
4.9±1.1 |
0.52 |
0.4-0.9 |
0.236ns |
|
β2GPI IgG (AU/ml) |
6.6±1.6 |
4.3±1.2 |
0.99 |
0.81-1.2 |
0.122ns |
|
Lupus (sec) |
40.3±5.2 |
36±6.0 |
0.58 |
0.42-1.0 |
0.315ns |
P value significant at 0.05, RR: Risk Ratio, %CI: Confidence interval, SE: Standard error. Anti-cardiolipin (ACL), β-2 glycoprotein I (β2GPI), Lupus, ns: not significant.